| 臺大學術典藏 |
2015 |
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study
|
Lin, W.-C. ; Kuo, K.-L. ; Shi, C.-S. ; Wu, J.-T. ; Hsieh, J.-T. ; Chang, H.-C. ; Liao, S.-M. ; Chou, C.-T. ; Chiang, C.-K. ; Chiu, W.-S. ; Chiu, T.-Y. ; Pu, Y.-S. ; Ho, I.-L. ; Wang, Z.-H. ; Chang, S.-C. ; Liu, S.-H. ; Jeng, Y.-M. ; Huang, K.-H.; CHIH-KANG CHIANG |
| 臺大學術典藏 |
2015 |
The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer
|
Chen C.-H.; Yu H.-J.; Lai M.-K.; Cheng A.-L.; Liu S.-P.; Pu Y.-S.; CHIA-HSIEN CHENG; Lan K.-H.; Wang C.-C.; Wang Y.-J.;Huang C.-Y.;Hou W.-H.;Wang C.-C.;Lan K.-H.;Chen C.-H.;Yu H.-J.;Lai M.-K.;Cheng A.-L.;Liu S.-P.;Pu Y.-S.;Chia-Hsien Cheng; Wang Y.-J.; Huang C.-Y.; Hou W.-H. |
| 臺大學術典藏 |
2014 |
Metallic ureteral stents in malignant ureteral obstruction: Clinical factors predicting stent failure
|
Chow P.-M.; Hsu J.-S.; Huang C.-Y.; Wang S.-M.; Lee Y.-J.; Huang K.-H.; Yu H.-J.; Pu Y.-S.; PO-CHIN LIANG |
| 臺大學術典藏 |
2014 |
Emphysematous pyelonephritis: Clinical characteristics and prognostic factors
|
Huang C.-Y.; PO-REN HSUEH; Pu Y.-S.; Chen C.-H.; Pong Y.-H.; Chiang B.-J.; Lu Y.-C.; Lu Y.-C.;Chiang B.-J.;Pong Y.-H.;Chen C.-H.;Pu Y.-S.;Po-Ren Hsueh;Huang C.-Y. |
| 臺大學術典藏 |
2013 |
Case report
|
Chia-Chi Lin; Wang J.-Y; Pu Y.-S. |
| 臺大學術典藏 |
2013 |
Reply to S. Vale
|
Lin C.-C.; JANN-YUAN WANG; Pu Y.-S. |
| 中國醫藥大學 |
2012-11 |
Joint Effect of Arsenic Methylation Profile and NNK Metabolites on Urothelial Carcinoma
|
(Wu,C.C.);(Su,C.T.);(Lee,H.L.);鍾季容(Chi-Jung Chung);(Huang,C.Y.);(Pu,Y.S.);(Lin,P.);(Hsueh,Y.M.)* |
| 中國醫藥大學 |
2011-09 |
The polymorphisms of P53 codon 72 and MDM2 SNP309 and renal cell carcinoma risk in a low arsenic exposure area
|
(Huang,C.Y.);(Su,C.T.);(Chu,J.S.);(Huang,S.P.);(Pu,Y.S.);(Yang,H.Y.);鍾季容(Chi-Jung Chung);(Wu,C.C.);(Hsueh,Y.M.)* |
| 中國醫藥大學 |
2011-06 |
Effect of urinary total arsenic level and estimated glomerular filtration rate on the risk of renal cell carcinoma in a low arsenic exposure area
|
(Huang,C.Y.); (Chu,J.S.); (Pu,Y.S.); (Yang,H.Y.); (Wu,C.C.); 鍾季容(Chi-Jung Chung); (Hsueh,Y.M.)* |
| 中國醫藥大學 |
2011-04 |
Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk
|
鍾季容(Chi-Jung Chung); (Lee,H.L.); (Yang H.Y.); (Lin P.); (Pu Y.S.); (Shiue H.S.); (Su C.T.); (Hsueh Y.M.)* |
| 中國醫藥大學 |
2011-01 |
Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma.
|
鍾季容(Chi-Jung Chung); (Pu Y.S.); (Su C.T.); (Huang C.Y.); (Hsueh Y.M.)* |
| 中國醫藥大學 |
2011-01 |
Protective effects of plasma alpha-tocopherols on the risk of inorganic arsenic-related urothelial carcinoma.
|
鍾季容(Chi-Jung Chung); (Pu Y.S.); (Chen Y.T.); (Su C.T.); (Wu C.C.,); (Shiue H.S.); (Huang C.Y.); (Hsueh Y.M.)* |
| 臺北醫學大學 |
2011 |
The Polymorphisms of P53 codon 72 and MDM2 SNP309 and Renal Cell Carcinoma Risk in a Low Arsenic Exposure Area
|
Huang, C.Y.;Su, C.T.;Chu, J.S.;Huang, S.P.;Pu, Y.S.;Yang, H.Y.;Chung, Chung C.J.;Wu, C.C.;Hsueh, Y.M. |
| 中國醫藥大學 |
2010-06 |
Polymorphisms in One-Carbon Metabolism Pathway Genes, Urinary Arsenic Profile and Urothelial Carcinoma.
|
鍾季容(Chi-Jung Chung); (Pu Y.S.); (Su C.T.,); (Chen H.W.); (Hunag Y.K.); (Shiue H.S.); (Hsueh Y.M.)* |
| 國立臺灣大學 |
2009-03 |
Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma
|
Huang, S.K.; Chiu, A.W.; Pu, Y.S.; Huang, Y.K.; Chung, C.J.; Tsai, H.J.; Yang, M.H.; Chen, C.J.; Hsueh, Y.M. |
| 中國醫藥大學 |
2009-03 |
Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma.
|
(Huang, S. K.); (Chiu, A. W.); (Pu, Y. S.); (Huang, Y. K.); 鍾季容(Chi-Jung Chung); (Tsai, H. J.); (Yang, M. H.); (Chen, C. J.); (Hsueh, Y. M.)* |
| 中國醫藥大學 |
2008-12 |
Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients.
|
(Lee, H. L.); (Hsueh, Y. M.); 鍾季容(Chi-Jung Chung); (Pu, Y. S.); (Chang, L. W.); (Hsieh, D. P.); (Liou, S. H.); (Lin, P.)* |
| 中國醫藥大學 |
2008-07 |
Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
|
鍾季容(Chi-Jung Chung); (Huang, C. J.); (Pu, Y. S.); (Su, C. T.); (Huang, Y. K.); (Chen, Y. T.); (Hsueh, Y. M.)* |
| 中國醫藥大學 |
2008-06 |
Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas.
|
(Huang, S. K.); (Chiu, A. W.); (Pu, Y. S.); (Huang, Y. K.); 鍾季容(Chi-Jung Chung); (Tsai, H. J.); (Yang, M. H.); (Chen, C. J.); (Hsueh, Y. M.)* |
| 中國醫藥大學 |
2008-03 |
Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility.
|
(Huang, Y. K.); (Pu, Y. S.); 鍾季容(Chi-Jung Chung); (Shiue, H. S.); (Yang, M. H.); (Chen, C. J.); (Hsueh, Y. M.)* |
| 中國醫藥大學 |
2008-01 |
Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area.
|
鍾季容(Chi-Jung Chung); (Huang, C. J.); (Pu, Y. S.); (Su, C. T.); (Huang, Y. K.); (Chen, Y. T.); (Hsueh, Y. M.)* |
| 中國醫藥大學 |
2007-01 |
Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.
|
(Pu, Y. S.); (Yang, S. M.); (Huang, Y. K.); 鍾季容(Chi-Jung Chung); (Huang, S. K.); (Chiu, A. W.); (Yang, M. H.); (Chen, C. J.); (Hsueh, Y. M.)* |
| 臺大學術典藏 |
2007 |
Set-up errors due to endorectal balloon positioning in intensity modulated radiation therapy for prostate cancer
|
Wang C.-W.;Chong F.-C.;Lai M.-K.;Pu Y.-S.;Wu J.-K.;Chia-Hsien Cheng; Wang C.-W.; Chong F.-C.; Lai M.-K.; Pu Y.-S.; Wu J.-K.; CHIA-HSIEN CHENG |
| 臺大學術典藏 |
2004 |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts
|
Tsuei D.-J.;Hsu H.-C.;Lee P.-H.;Jeng Y.-M.;Pu Y.-S.;Chen C.-N.;Lee Y.-C.;Chou W.-C.;Chang C.-J.;Ni Y.-H.;Mei-Hwei Chang; Tsuei D.-J.; Hsu H.-C.; Lee P.-H.; Jeng Y.-M.; Pu Y.-S.; Chen C.-N.; Lee Y.-C.; Chou W.-C.; Chang C.-J.; Ni Y.-H.; MEI-HWEI CHANG |
| 臺大學術典藏 |
1995 |
Tamoxifen Enhances the Chemosensitivity of Bladder Carcinoma Cells
|
Pu Y.-S.;Hsieh T.-S.;Tsai T.-C.;Cheng A.-L.;Chang-Yao Hsieh;Su I.-J.;Lai M.-K.; Pu Y.-S.; Hsieh T.-S.; Tsai T.-C.; Cheng A.-L.; CHANG-YAO HSIEH; Su I.-J.; Lai M.-K. |
